Abstract:The prevalence of Alzheimer's disease (AD) continues to rise due to the increasing aging population. Among the various genetic factors associated with AD, apolipoprotein E (ApoE), a lipid transporter, stands out as the primary genetic risk factor. Specifically, individuals carrying the ApoE4 allele exhibit a significantly higher risk. However, emerging research indicates that dietary factors play a prominent role in modifying the risk of AD. Docosahexaenoic acid (DHA), a prominent ω-3 fatty acid, has garnered considerable attention for its potential to ameliorate cognitive function. The intricate interplay between DHA and the ApoE genotype within the brain, which may influence DHA's utilization and functionality, warrants further investigation. This review meticulously examines experimental and clinical studies exploring the effects of DHA on cognitive decline. Special emphasis is placed on elucidating the role of ApoE gene polymorphism and the potential underlying mechanisms are discussed. These studies suggest that early DHA supplementation may confer benefits to cognitively normal older adults carrying the ApoE4 gene. However, once AD develops, ApoE4 non-carriers may experience greater benefits compared to ApoE4 carriers, although the overall effectiveness of DHA supplementation at this stage is limited. Potential mechanisms underlying these differential effects may include accelerated DHA catabolism in ApoE4 carriers, impaired transport across the blood-brain barrier (BBB), and compromised lipidization and circulatory function in ApoE4 carriers. Thus, the supplementation of DHA may represent a potential intervention strategy aimed at compensating for these deficiencies in ApoE4 carriers prior to the onset of AD.

Comparative Study of the Effects of Phosphatidylcholine Rich in DHA and EPA on Alzheimer's Disease and the Possible Mechanisms in CHO-APP/PS1 Cells and SAMP8 Mice

A comparative study of the effects of phosphatidylserine rich in DHA and EPA on Aβ-induced Alzheimer's disease using cell models

Comparative Analyses of DHA‐Phosphatidylcholine Forage and Liposomes on Alzheimer's Disease in SAMP8 Mice

A Comparative Study of EPA-enriched Ethanolamine Plasmalogen and EPA-enriched Phosphatidylethanolamine on Aβ42 Induced Cognitive Deficiency in a Rat Model of Alzheimer's Disease

A Comparative Study of Eicosapentaenoic Acid Enriched Phosphatidylcholine and Ethyl Ester in Improving Cognitive Deficiency in Alzheimer's Disease Model Rats.

Mechanisms of DHA-enriched Phospholipids in Improving Cognitive Deficits in Aged SAMP8 Mice with High-Fat Diet

Comparative Studies of DHA-enriched Phosphatidylcholine and Recombination of DHA-ethyl Ester with Egg Phosphatidylcholine on Ameliorating Memory and Cognitive Deficiency in SAMP8 Mice.

EPA Enriched Ethanolamine Plasmalogens Significantly Improve Cognition of Alzheimer’s Disease Mouse Model by Suppressing Β-Amyloid Generation

Effects of Dietary Supplementation with EPA-enriched Phosphatidylcholine and Phosphatidylethanolamine on Glycerophospholipid Profile in Cerebral Cortex of SAMP8 Mice Fed with High-fat Diet

A Comparative Study about the Neuroprotective Effects of DHA-Enriched Phosphatidylserine and EPA-Enriched Phosphatidylserine Against Oxidative Damage in Primary Hippocampal Neurons.

DHA-PC and DHA-PS Improved Aβ1–40 Induced Cognitive Deficiency Uncoupled with an Increase in Brain DHA in Rats

Comparative Study of Different Polar Groups of EPA‐Enriched Phospholipids on Ameliorating Memory Loss and Cognitive Deficiency in Aged SAMP8 Mice

Docosahexaenoic Acid-Phosphatidylcholine Improves Cognitive Deficits in an Aβ23-35-Induced Alzheimer's Disease Rat Model.

Effects of Astaxanthin and Docosahexaenoic-Acid-Acylated Astaxanthin on Alzheimer's Disease in APP/PS1 Double-Transgenic Mice.

The Protective Effect of Eicosapentaenoic Acid-Enriched Phospholipids from Sea Cucumber Cucumaria Frondosa on Oxidative Stress in PC12 Cells and SAMP8 Mice

Effects of Docosahexaenoic Acid-Phosphatidylcholine Liposomes on Dementia Induced by Scopolamine in Mice

Metabotyping of Docosahexaenoic Acid - Treated Alzheimer’s Disease Cell Model

Eicosapentaenoic Acid Enriched Phosphatidylcholine Mitigated Aβ1-42 Induced Neurotoxicity Via Autophagy-Inflammasome Pathway.

Effects of DHA on cognitive dysfunction in aging and Alzheimer's disease: The mediating roles of ApoE

Supplementation of Medium-Chain Triglycerides Combined with Docosahexaenoic Acid Inhibits Amyloid Beta Protein Deposition by Improving Brain Glucose Metabolism in APP/PS1 Mice

Recovery of brain DHA-containing phosphatidylserine and ethanolamine plasmalogen after dietary DHA-enriched phosphatidylcholine and phosphatidylserine in SAMP8 mice fed with high-fat diet